Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved

Updated on: March 06,2024

Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved

Updated on:March 06,2024

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It

Updated on: February 24,2024

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It

Updated on:February 24,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on: January 12,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on:January 12,2024

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on: January 12,2024

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on:January 12,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on: June 15,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on:June 15,2024

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w

Updated on: January 29,2024

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w

Updated on:January 29,2024

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on: January 02,2024

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on:January 02,2024

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula

Updated on: March 30,2024

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula

Updated on:March 30,2024

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers

Updated on: February 23,2024

Researchers present advance in re-treatment with CAR T therapy

by Perelman School of Medicine at the University of PennsylvaniaHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Researchers

Updated on:February 23,2024

Researchers identify genetic 'seeds' of metastatic breast cancer

by UNC Lineberger Comprehensive Cancer CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast cancer is the second leading cause of cancer d

Updated on: March 01,2024

Researchers identify genetic 'seeds' of metastatic breast cancer

by UNC Lineberger Comprehensive Cancer CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast cancer is the second leading cause of cancer d

Updated on:March 01,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on: April 22,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on:April 22,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on: January 02,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on:January 02,2024